Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy)

Clinical Microbiology and Infection

Volumn 15, Issue 4, 2009, Pages 347-357

  D'Arezzo, S ^a   Capone, A ^a   Petrosillo, N ^a   Visca, P ^a,b   Ballardini, M ^c   Bartolini, S ^c   Bordi, E ^c   Di Stefano, A ^c   Galie M ^c   Minniti, R ^c   Meledandri, M ^c   Pacciani, L ^c   Parisi, G ^c   Prignano, G ^c   Santini, C ^c   Valmarin, M ^c   Venditti, M ^c   Ziantoni, S ^c  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

^c NONE

Author keywords

Acinetobacter baumannii; Epidemiology; Integrons; Multidrug resistance; Nosocomial infection; Typing

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; CONTROLLED STUDY; EPIDEMIC; GENE REARRANGEMENT; GEOGRAPHIC DISTRIBUTION; INFECTION RISK; INTENSIVE CARE; ITALY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; RESTRICTION MAPPING;

ACINETOBACTER BAUMANNII;

EID: 65449183403     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02668.x     Document Type: Article

References (45)

1. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med 2008; 358: 1271-1281.
2. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5: 939-951.
3. Abbo A, Navon-Venezia S, Hammer-Muntz O et.al. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005; 11: 22-29.
4. Coelho JM, Turton JF, Kaufmann ME et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 2006; 44: 3623-3627.
5. Dijkshoorn L, Aucken H, Gerner-Smidt P et al. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol 1996; 34: 1519-1525.
6. Nemec A, Dijkshoorn L, van der Reijden TJ. Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J Med Microbiol 2004; 53: 147-153.
7. Nemec A, Janda L, Melter O et al. Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii isolates in the Czech Republic. J Med Microbiol 1999; 48: 287-296.
8. Brisse S, Milatovic D, Fluit AC et al. Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping. J Clin Microbiol 2000; 38: 3636-3645.
9. Spence RP, van der Reijden TJ, Dijkshoorn L et al. Comparison of Acinetobacter baumannii isolates from United Kingdom hospitals with predominant Northern European genotypes by amplified-fragment length polymorphism analysis. J Clin Microbiol 2004; 42: 832-834.
10. van Dessel H, Dijkshoorn L, van der Reijden T et al. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol 2004; 155: 105-112.
11. Nemec A, Dolzani L, Brisse S et al. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol 2004; 53: 1233-1240.
12. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006; 42: 692-699.
13. Iacono M, Villa L, Fortini D, et al. Whole genome pyrosequencing of an epidemic multidrug resistant Acinetobacter baumannii of the European clone II. Antimicrob Agents Chemother 2008; 52: 2616-2625.
14. Koeleman JG, Stoof J, Van Der Bijl MW et al. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol 2001; 39: 8-13.
15. Villari P, Iacuzio L, Vozzella EA et al. Unusual genetic heterogeneity of Acinetobacter baumannii isolates in a university hospital in Italy. Am J Infect Control 1999; 27: 247-253.
16. Zarrilli R, Crispino M, Bagattini M et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol 2004; 42: 946-953.
17. Agodi A, Zarrilli R, Barchitta M et al. Alert surveillance of intensive care unit-acquired Acinetobacter infections in a Sicilian hospital. Clin Microbiol Infect 2006; 12: 241-247.
18. Giordano A, Varesi P, Bertini A et al. Outbreak of Acinetobacter baumannii producing the carbapenem-hydrolyzing oxacillinase OXA-58 in Rome, Italy. Microb Drug Resist 2007; 13: 37-43.
19. Bertini A, Giordano A, Varesi P et al. First report of the carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy. Antimicrob Agents Chemother 2006; 50: 2268-2269.
20. Longo B, Pantosti A, Luzzi I et al. An outbreak of Acinetobacter baumannii in an intensive care unit: Epidemiological and molecular findings. J Hosp Infect 2006; 64: 303-305.
21. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing, Seventeenth informational supplement. M100-S17. Wayne, PA: CLSI, 2007.
22. Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: Review of available interpretative criteria and quality control guidelines. J Clin Microbiol 2001; 39: 183-190.
23. Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006; 43 (suppl): 43S-48S.
24. Dijkshoorn L, Van Harsselaar B, Tjernberg I et al. Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species. Syst Appl Microbiol 1998; 21: 33-39.
25. Vaneechoutte M, Dijkshoorn L, Tjernberg I et al. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 1995; 33: 11-15.
26. Grundmann HJ, Towner KJ, Dijkshoorn L et al. Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol 1997; 35: 3071-3077.
27. Carr E, Eason H, Feng S et al. RAPD-PCR typing of Acinetobacter isolates from activated sludge systems designed to remove phosphorus microbiologically. J Appl Microbiol 2001; 90: 309-319.
28. Seifert H, Dolzani L, Bressan R et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005; 43: 4328-4335.
29. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
30. Struelens MJ, Schwam V, Deplano A et al. Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients. J Clin Microbiol 1993; 31: 2320-2326.
31. Turton JF, Gabriel SN, Valderrey C et al. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 2007; 13: 807-815.
32. Ploy MC, Denis F, Courvalin P et al. Molecular characterization of integrons in Acinetobacter baumannii: Description of a hybrid class 2 integron. Antimicrob Agents Chemother 2000; 44: 2684-2688.
33. Sambrook JE, Fritsch F, Maniatis T. Molecular cloning: A laboratory manual, 2th edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
34. Poirel L, Marque S, Heritier C et al. OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49: 202-208.
35. Woodford N, Ellington MJ, Coelho JM et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27: 351-353.
36. Turton JF, Ward ME, Woodford N et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006; 258: 72-77.
37. Turton JF, Kaufmann ME, Glover J et al. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J Clin Microbiol 2005; 43: 3074-3082.
38. Da Silva G, Dijkshoorn L, van der Reijden T et al. Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as subgroup of European clone II. Clin Microbiol Infect 2007; 13: 190-195.
39. Fournier PE, Vallenet D, Barbe V et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006; 2: E7.
40. Smith MG, Gianoulis TA, Pukatzki S et al. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 2007; 21: 601-614.
41. Valenzuela JK, Thomas L, Partridge SR et al. Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J Clin Microbiol 2007; 45: 453-460.
42. Corbella X, Ariza J, Ardanuy C et al. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Chemother 1998; 42: 793-802.
43. Peleg AY, Adams J, Paterson DL. Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51: 2065-2069.
44. Gombac F, Riccio ML, Rossolini GM et al. Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays. Antimicrob Agents Chemother 2002; 46: 3665-3668.
45. Towner KJ, Levi K, Vlassiadi M et al. Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe. Clin Microbiol Infect 2008; 14: 161-167.